ICL Group Ltd

Good morning ladies and gentlemen and welcome to the ICL first quarter 2025 earnings call. At this time all lines are in listen only mode. Following the presentation we will conduct a question and answer session. If at any time during this call require immediate assistance please press star zero for the operator. This call is being recorded on Monday May 19, 2025 and I would like to turn the conference over to Peggy Riley-Tarp VP ICL Global Investor Relations. Please go ahead.

Thank

you.

Hello everyone. I'm Peggy Riley-Tarp Vice President of Global Investor Relations for ICL. I'd like to welcome you and thank you for joining us today for our earnings conference call. This event is being webcast live on our website at -group.com and there will be a replay available a few hours after the live call and a transcript will be available shortly thereafter. Earlier today we filed our reports and our presentation with securities authorities and the stock exchanges in both Israel and the United States. Those reports as well as the press release and our presentation are available on our website. Please be sure to review the disclaimer on slide two of the presentation. Our comments today will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are not guarantees of future performance. Company undertakes no obligation to update any information discussed on this call at any time. We will begin with the presentation by our CEO Mr. Elad Aaronson followed by Mr. Abraham Lahav, our CFO. After the presentation we will open the line for the Q&A session and I would now like to turn the call over to Elad.

Thanks, Peggy, and welcome everyone and thank you all for joining us for the first quarter 2025 earnings call. It has been an interesting and busy first few months for me and I'm pleased to share our results with you today. Now if you will please turn to slide three for a brief overview of the quarter. Sales were ,000,000 up 2% -over-year and up 10% on January 1st. Quarterly basis as the company demonstrated solid strategic execution. Specialties driven sales of ,000,000 were up 3% versus the first quarter of last year and up 15% versus fourth quarter. Consolidated adjusted EBITDA was ,000,000 while Specialties driven EBITDA of ,000,000 was up 7% -over-year and 4% on a quarterly basis. Specialties driven EBITDA margin of 19% improve approximately 70 basis points versus the first quarter of last year. Overall market pricing trends begin to gradually improve in the first quarter. However, I would remind you that for many of our businesses there is a timing gap between published and realized prices. Nonetheless, fertilizer fundamentals are strengthening and there seems to be a feeling of general optimism. We are of course monitoring the global tariff and trade situation and developing different mitigation responses. In addition, we expect to leverage our already well-established regional production to continue to drive global growth with local focus and Aviram will elaborate on this a little bit later in the call. Our diversified global approach allows our Specialties businesses focus on local production for our customers and to provide customized solutions for the specific needs. Additionally, at present there are no tariffs on potash and bear in mind that we are able to reallocate products between markets as needed. Let's start with a review of our divisions and begin with our industrial products business on slide 4. For the first quarter, sales of $344 million were up 3% versus the first quarter of last year, while EBITDA of $76 million was up 6%. EBITDA margin improved to 22% and increased of 60 basis points. This solid performance reflects good quarterly trends which benefited from higher volume. Better volumes drove our overall retardant sales to increase year over year with brominated product sales up slightly. Post-force based flame retardant improved on both higher volumes, mainly in the US and in Europe, and also higher prices. Some of these improvements is related to a recent anti-dumping measures implemented in the EU in 2024 and now also in the US. And we will continue to protect our markets when necessary. While trends are generally improving, some of our key flame retardant end markets, such as electronics and especially building and construction, are still somewhat subdued. Bromine market prices picked up in the first quarter, but there have been different price fluctuations since that time related to ever changing global tariffs and trade news. Regardless, change creates opportunities and this is where our focus on R&D and innovation really stands out. It allows us to create solutions to help our existing customers with issues they might be experiencing and also enables us to develop targeted solutions for new customers. On slide five, you will see our potash division results for the first quarter with sales of $405 million and EBITDA of $118 million. Our average potash price for the first quarter was $300 per tonne, down when compared to the first quarter of last year, but up $15 per tonne over the fourth quarter. As a reminder, similar to Bromine prices, potash price improvement is not immediately reflected in our results, as there is a gap of anywhere from two to three months. In the first quarter, potash sales volumes of ,103,000 metric tons increased by about 20,000 tons year over year, with higher volumes mainly to Brazil and China. I would point out that even as we were obligated to fulfill our annual 2024 contracts with China and India, which are at lower prices than the current market price, we still work to maximize the profitability of our potash resources and to prioritize supply to the best global markets when possible. For the second quarter, we expect to deliver approximately another 150,000 tons China and India under the existing contracted rates. As you see, in the first quarter, we addressed some operational issues related in part to the war, and in April, we completed a full and successful maintenance shutdown there. We invested to stabilize operations and expect these efforts to help to drive improved output and efficiency as the year progresses. At our potash operations in both Spain and Israel, we remain intent to driving operational and efficiency efforts. In Spain, we are focused on debuzzle-necking and also using innovation to optimize mining activity, improve reliability, and to meet sustainability targets. Turning to slide six, and our phosphate solutions division, where first quarter sales of $573 million were up 3%, while EBITDA of $139 million increased 6%, and EBITDA margin expanded to 24%. The improvement in the quarter was generally driven by strength in commodities due to firm global demand and higher prices. As expected, our phosphate specialties results were in line with market dynamics, as pricing remained under pressure due to overcapacity of purified phosphoric acid, including DPA and WPA. Industrial phosphate saw increases in both sales and volume in all major regions. However, an increase in food phosphate volume was not able to offset lower market prices. In China, sales for our YPA joint venture increased year over year, with higher prices and volumes and favorable product mix. As a reminder, our YPH operations serve both phosphate commodities and specialties, and also growing solution business. And the team there does an excellent job of optimizing its resources. We recently had a management change in phosphate solutions, and Nadav Thuner, who successfully served as CEO of YPH for the past five years, has been appointed president of phosphate solutions, replacing Phil Brown. The business will continue to be focused on maintaining market share and volume gains, and on targeting geographic expansion for both the food and industrial specialty phosphate solutions. Turning now to slide seven, and our growing solutions business division, where first quarter sales of $495 million were up 3% year over year, while EBITDA of $47 million increased 12%. This improvement was driven by a solid strategic execution of our growth plan, including the addition of regional acquisitions in 2024, like custom ad formulators in the US and GreenVest in the UK, and as we expanded locally in China. We saw higher sales in China in the first quarter with strong volume growth and meaningful contribution from our bio-stimulant product offerings. In North America, we saw strong start of the year with both higher sales and profitability due to good demand for specialty fertilizers. In Brazil, sales increased year over year as did volumes, and both B2B and B2C sales also improved. Going forward, we expect Brazil to be a beneficiary of recent uncertainty related to tariffs, and we plan to maximize our business there to benefit from any shifts in global trade. In Europe, so good growth in our turf and ornamental business, and we expect to continue to drive growth from our innovative new offerings and a shift in bio-stimulant products. As you know, Biologicals has been a big focus for ICL, and in early April, we acquired LaviBio, a leading ag-biological technology company. This acquisition further advances our goal of becoming a global powerhouse in ag-biologicals and helps us to position ICL at the forefront of this vibrant and sustainable new market. This is in addition to other innovative new products we have developed including the recent launch of Bios in Italy, Poland, France, Spain, and Germany. Bios is new range of bio-stimulants for Europe, which was engineered to ensure crops reach their full potential by improving establishment, promoting growth, increasing flowering and fruit setting, and enhancing tolerance to and recovery from stress. And with this, I would now like to send call over to Aviram for a brief financial overview before I share an update on our guidance and outlook for 2025.

Thank you a lot and to all of you for joining us today. Let us get started on slide nine and take a look at some key market metrics. As a truly global company supplying a wide variety of end markets, we look at the number of macro metrics including inflation. Rates were fairly stable for the U.S. and EU in the first quarter, but Brazil saw a 30 basis point increase. In China, inflation turned slightly negative by quarter end as consumer prices fell by 0.1 percent year over year in March, marking the second consecutive monthly decrease. Turning to interest rates, which increased again in Brazil this quarter, up approximately 200 basis points versus the fourth quarter of 2024. Rates in the U.S. and Israel were flat in the first quarter, while the EU, UK, and India also decreases of between 20 to 50 basis points. Global industrial production growth was 2.9 percent in the first quarter, up approximately 80 basis points versus the fourth quarter. Growth is forecasted to ease in the second quarter and then level off to 3.1 percent for the remainder of 2025. Lastly, on this slide, let us look at first quarter housing starts in the U.S., which decreased 13 percent after improving at roughly the same rate in the fourth quarter of 2024. Turning to slide 10 and key fertilizer market metrics, which are clearly relevant for our business, but also for growing solutions and fostering. In the first quarter, the grain price index was up slightly on a sequential basis. Corn, wheat, and soybean prices all improved, with corn seeing both the biggest quarterly gain and growth on a year over year basis. In the U.S., corn annually uses more than 2 million tons of potash, and that is about a million tons more than the amount used by soybean crops and significantly more than wheat. Farmer sentiment in the first quarter increased slightly on a sequential basis, but was up significantly versus the first quarter of last year. In April, farmer sentiment improved further, with increases in both current conditions and future expectations. As farmers overwhelmingly reported that they expect the increased use of tariffs by the U.S. to prove beneficial to the agricultural economy in the long run. Potash and phosphate prices both increased sequentially in the first quarter. Potash prices up approximately 9 percent, while phosphate growth was at approximately 4 percent, as the chart data shows. In the first quarter, ocean trade rates increased by about 8 percent sequentially, but were down nearly 30 percent versus the first quarter of last year. Turning to slide 11 and some new market indicators, which are more relevant for our industrial products and phosphate solution businesses. Let us start with Chinese growing prices, which improved in the first quarter and have fluctuated down and then back up since quarter end. While there are no available forecasts for growing prices, there are for specialty phosphate demand, which is expected to continue to increase at a steady pace over the next five years. Since 2020, global demand for LFP-grade phosphate grew at a more than 100 percent, while technical MAP improved at the most of the days, but still impressed a pace of 17 percent. As many of you know, we currently produce LFP-grade phosphates for use in EV batteries in China. However, we also supply bromine and phosphate-based solutions to the global auto market, which is expected to grow approximately 25 percent over the next 15 years. From semiconductor chips to wind sheets and from seats to tires, ICL solutions make cars safer and more efficient. They even make the roads we drive on smoother and safer by extending the life of asphalt and preventing potholes. So regardless of what kind of engine your next car has, we are important and necessary part of the automotive end market. Our bromine and phosphate solutions are also used in many everyday consumer goods, including pharmaceutical products and food and beverages. Over the past five years, revenues for the consumer products industry have improved more than seven percent. While companies have relied on price increases for some of this expansion, they have also looked to innovation and efficiency to drive profits and growth, and our specialty solutions have helped them achieve their goals. If you will now turn to slide 12 for a look at our -over-year sales bridges, for the first quarter, sales came at ,000,000, up two percent versus last year. On the left side, you can see the change of each of our business divisions with all excluding potash demonstrating growth. Turning to the right of the slide, you can see the benefit received from high equities but also the impact of lower prices and exchange rate fluctuations on -over-year sales growth. On slide 13, you can once again see the impact lower potash prices had on our first quarter EBITDA of ,000,000.

We were, however,

able to offset some of the pricing cuts to overall higher quantities and lower raw material and transportation costs. Turning to slide 14, and a look at some of our leading positions in terms of cost, quality, and price, even as we continue to service our 2024 potash contracts with China and India in the first quarter, we still maintain our leadership position in terms of average real life potash price. On the right side of the slide, you can see ICL leadership position in the global bromine market. Bromine prices appear to be somewhat stabilizing and the Dead Sea remains the most cost-competitive source of bromine and accounts for approximately two-thirds of global supply capacity. If you turn to slide 15, you can see how our global business looks on both the divisional and regional basis. For the first quarter, Europe represented approximately 35% of sales, with Asia at 24%, North America came in at 20%, and South America represented 16% of total sales. I would like to stress the importance of our regional strategy by asking you to turn to slide 16. Here you can see the breadth and depth of ICL's footprint. In total, we operate more than 40 production sites in 13 different countries, with many of our specialty products manufactured and sold regionally. For example, between 60 to 70% of our specialty sales in the U.S. are produced in the U.S., and this is an important strategic advantage for ICL. Additionally, as potash is exempt from US tariffs, we believe the implication of the new global trade situation will not be materialized by ICL. Before I turn the call back over to Elad, I would like to share a few highlights on slide 17. Our balance sheet remains strong, and we ended the quarter with available resources of approximately $1.5 billion. Our net debt to adjust the EBITDA rate at quarter end remained at 1.2 times, and we delivered operating cash flow of $165 million. Once again, we are distributing 50% of adjusted net income for our shareholders, which translates to a total dividend of $55 million this quarter, resulting in a trading 12-month dividend yield of 3.5%. In the quarter, we maintained our consistent and disciplined approach to capital allocation and also remained focused on cost savings and efficiency efforts. And with that, I would like to turn the call back over to Elad for a review of our guidance.

Thank you, Aviram. If you will turn to slide 19, I would like to confirm that we are maintaining our 2025 guidance. For our specialty-driven business which includes industrial products, growing solutions, and phosphate solutions, we continue to expect EBITDA to be between $0.95 billion to $1.15 billion in 2025. We expect potash sales volumes to be between $4.5 million to $4.7 million metric tons. And we expect our effective annual tax rates for 2025 to be approximately 30% in anticipation of higher potash prices. However, I would remind everyone once again that we will still be fulfilling our annual potash contracts with China and India in the second quarter. In addition, our annual potash guidance does not include price parameters. However, we support the market expectation that prices will increase. Additionally, we have not made any guidance concessions for potential tariffs. As we await further clarity on this topic. With that said, our calculation based on the current situation indicates any impact for 2025 would be the minimist. However, we are aware of the possibility for further changes. On slide 20, you can see a few of the areas we are focused on this year. While there has been a change in the leadership at ICL, and I plan to share more clarity about my vision for the company later this year, there has not been a shift in our overall strategy. We will continue to drive growth in our specialty businesses, which help to differentiate ICL from our more commodity based peers. We will also continue to maximize our potash sales volumes by prioritizing the market with the highest prices when possible, as we have done in the past. Market prices are improving in many areas, including for potash and bromine, and we expect to benefit from higher rates as the year progresses. But we do not intend to rely on just passing through price increases for growth. Rather, we will continue to drive cost savings efficiency. We will also look to operational enhancement to address some of our recent production issues. Innovation will remain key to ICL's future growth, and we will continue to develop new products in partnership with existing clients and to provide solutions to new clients. Our acquisition strategy remains the same, and you can expect to see additional complementary M&A activities. Indeed, some of our recent acquisitions, like custom ad formulators, have helped to expand our presence in regional markets and allows us to provide local production for local customers, and we have been moving in this direction for quite some time. This is one of the benefits of having a truly global workforce. It enables us to look to our trusted co-workers in different regions for their insights and to work with them on finding the right solutions.

I would like

to thank all of my colleagues around the world for a good quarter, and I look forward to sharing many more with them. And with that, I would like to turn the call back over to the operator for Q&A.

Thank you. Ladies and gentlemen, we will now begin the question and answer session. Should you have a question, please press star followed by the one on your telephone keypad. You will hear a prompt that your hand has been raised, and should you wish to cancel your request, please press star followed by the two. If you are using your speakerphone, please lift the handset before pressing any keys. One moment, please, for your first question. Your first question comes from the line of Benjamin Turer from Berkeley. Please go ahead.

Hi, everyone. This is Rahi on for Ben. First off, congrats on the results. Just wanted to zoom into potash. Do you see any different trade flows with the Eurasian players saying that to shut down capacity in 2Q? There are some market ideas that these players, if they produce above their normal capacity utilization, maybe 96% versus their normal high 80%, then there won't be any undersupply, but just relative tightness given low spot availability. Just wondering what you think about that. Is it likely that they would perform that 96% capitalization, or what do you think the tightness will be in the market in 2Q, just ideas on that in terms of pricing impacts. Thank you so much.

Thank you. Rahi, can you repeat the first part of that question for me, please? Yeah, of course.

Here, easier if I talk like this. Right, so first, I'm asking if you see any different trade flows with the Eurasian players saying they're shut down capacity in 2Q. So just if you see anything different happening, if you actually see the impact from cut capacity as they had announced, and then again, there's some market ideas like some of our data platforms that if these Eurasian players produce above their normal capacity utilization, so I think normally it's high 80%, but if they go to maybe high 90s, there won't be undersupply, but still relative tightness. Just maybe what you think about that. If you think high 96% is normal, or sorry, high 96% is doable is the word. The same here is general tightness that could happen in 2Q.

I guess my question would be who are you lumping in with Eurasian players? That would be very key.

Oh, sorry. Yeah, of course. I'm going to pronounce some words. I'm a Eurochem, Ukraine, those three players that are

kind of- The Russian players?

Yeah, yeah, let's look at those two.

Well, there's been a lot in the news and even analyst reports that I'm sure you've seen which first those players say they're going to be not able to keep up to production, then they actually exceed expectations. To be honest with you, what they say and what they do isn't always the same thing, and obviously we do keep an eye on that, but I think it's actually kind of difficult to answer the question when they're a little bit, not very transparent in their actions if that helps at all. I think it looks like prices are moving in the right direction. Supply is pretty stable. Demand should be good. You heard what we said about corn and Padas in the US. My only caution, and I think a lot of me is very clear on the call, is that we know we still are supplying those India and China contracts for 2024, and we know they're at much lower rates, and that'll be going into the second quarter. So it'd be great if we would see more of that benefit from improving pricing, but it will be a little bit delayed for us if that helps at all.

Yeah, for sure. Thanks so much, Peggy. And then just wanted to see if you had more color on the mix shift that you mentioned for Brazil and growing solutions, and that would be it. Thank you so much.

Oh, sure. Excellent. Yes, Brazil had obviously good B2B and B2C business. Specialties are very strong there. So it's doing very well with the acquisitions we made several years ago. And I would say we saw something a little similar in North America where we added custom egg formulators in and in fact saw higher specialty growth for growing solutions there as well. And that's going around, actually, the world. We mentioned that in the EU we're seeing good bio-stimulant sales. So I hope that helps.

For sure. Thanks so much.

Thank you. Operator, do we have any further questions?

Thank you. Once again, should you have a question, please press star followed by the one on your telephone keypad. And there are no further questions at this time. I would now hand the call back to Peggy Riley, who is the director of the U.S. Department of Health and Human Services

at the University of Utah. Thank you so much for joining us today. We really appreciate you learning more about our first quarter results and we look forward to sharing our second quarter results with you later this summer. Take care.

And this concludes today's call. Thank you for participating. You may all disconnect.